Archives

Investigating the symmetry of fibrillar plaques on AD mouse models confirms an asymmetric pattern, similar to Alzheimer’s disease patients, which translated into regional microglia activation.

Modulating Trem2 signaling through Trem2 antagonistic antibodies can alter microglia function and cause disease-relevant changes in Alzheimer’s disease.

How a research question that has been open for decades could now be answered.